FR3054132B1 - Utilisation d’une combinaison d’hydrolysat peptidique de mais, de derive de vitamine c, de carnitine et d’adenosine pour augmenter la densite capillaire - Google Patents

Utilisation d’une combinaison d’hydrolysat peptidique de mais, de derive de vitamine c, de carnitine et d’adenosine pour augmenter la densite capillaire Download PDF

Info

Publication number
FR3054132B1
FR3054132B1 FR1670396A FR1670396A FR3054132B1 FR 3054132 B1 FR3054132 B1 FR 3054132B1 FR 1670396 A FR1670396 A FR 1670396A FR 1670396 A FR1670396 A FR 1670396A FR 3054132 B1 FR3054132 B1 FR 3054132B1
Authority
FR
France
Prior art keywords
hair
combination
carnitine
adenosine
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1670396A
Other languages
English (en)
Other versions
FR3054132A1 (fr
Inventor
Catherine Gondran
Corinne Coquet
Armelle Perrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR1670396A priority Critical patent/FR3054132B1/fr
Publication of FR3054132A1 publication Critical patent/FR3054132A1/fr
Application granted granted Critical
Publication of FR3054132B1 publication Critical patent/FR3054132B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne l'utilisation cosmétique d'une combinaison d'agents actifs comprenant un hydrolysat peptidique de maïs, de la vitamine C ou un de ses dérivés, de la carnitine et de l'adénosine pour stimuler ou restaurer la densité capillaire, stimuler la pousse du cheveu et des cils et ralentir la chute du cheveu et des cils. L'invention porte encore sur un procédé de soin cosmétique destiné à lutter contre le vieillissement du cheveu et protéger le cheveu des agressions extérieures. L'invention concerne également la combinaison d'agents actifs pour son utilisation pour stimuler et/ou restaurer la densité capillaire, augmenter la pousse du cheveu ou limiter la chute du cheveu, dans le cadre d'un traitement préventif ou curatif de la perte de cheveux liée à un état pathologique.
FR1670396A 2016-07-21 2016-07-21 Utilisation d’une combinaison d’hydrolysat peptidique de mais, de derive de vitamine c, de carnitine et d’adenosine pour augmenter la densite capillaire Active FR3054132B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1670396A FR3054132B1 (fr) 2016-07-21 2016-07-21 Utilisation d’une combinaison d’hydrolysat peptidique de mais, de derive de vitamine c, de carnitine et d’adenosine pour augmenter la densite capillaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1670396 2016-07-21
FR1670396A FR3054132B1 (fr) 2016-07-21 2016-07-21 Utilisation d’une combinaison d’hydrolysat peptidique de mais, de derive de vitamine c, de carnitine et d’adenosine pour augmenter la densite capillaire

Publications (2)

Publication Number Publication Date
FR3054132A1 FR3054132A1 (fr) 2018-01-26
FR3054132B1 true FR3054132B1 (fr) 2020-02-21

Family

ID=57485810

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1670396A Active FR3054132B1 (fr) 2016-07-21 2016-07-21 Utilisation d’une combinaison d’hydrolysat peptidique de mais, de derive de vitamine c, de carnitine et d’adenosine pour augmenter la densite capillaire

Country Status (1)

Country Link
FR (1) FR3054132B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8435572B2 (en) * 2008-12-03 2013-05-07 Elc Management, Llc Compositions and methods for promoting a relaxation state
CA2896646A1 (fr) * 2012-12-27 2014-07-03 Hayashibara Co., Ltd. Composition antivieillissement pour l'exterieur de la peau et son procede de production
CN103494754B (zh) * 2013-08-27 2015-09-23 星彤（上海）化妆品科技有限公司 草本精华和生化成分配方的防脱育发洗发露及其制备方法

Also Published As

Publication number Publication date
FR3054132A1 (fr) 2018-01-26

Similar Documents

Publication Publication Date Title
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
MX370963B (es) Composiciones para el cuidado personal.
WO2016042163A3 (fr) Compositions médicamenteuses ophtalmiques
MX2019007587A (es) Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
BR112017017448A2 (pt) métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho
MX2021010058A (es) Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel.
MX2017004536A (es) Composicion de capsula.
FR3061656B1 (fr) Hydrolysat de pichia minuta et utilisation cosmetique pour lutter contre la chute des cheveux et favoriser leur repousse
WO2016190682A3 (fr) Composition pour la prévention et le traitement de maladies musculaires ou pour l'amélioration de la fonction musculaire, contenant de la morusine, du kuwanon g, ou mori cortex radicis
PH12019502874A1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
WO2017015485A8 (fr) Préparation pour analogues d'anticholinergiques à potentiel modéré
BR112017019507A2 (pt) ?processo de tratamento cosmético dos cabelos?
FR3073721B1 (fr) Masque destine aux soins du visage
WO2015048503A3 (fr) Modulateurs négatifs n-arylméthyl sulfonamide de nr2a
MA39447B1 (fr) Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
EP3639839A4 (fr) Peptide à activité d'antidépresseur et effet thérapeutique contre la maladie d'alzheimer
MX2021012353A (es) Composicion cosmetica topica y usos de la misma.
BR112017015613A2 (pt) gel intestinal de levodopa e carbidopa e métodos de utilização
Balaji Dental caries: Research perspective
FR3054132B1 (fr) Utilisation d’une combinaison d’hydrolysat peptidique de mais, de derive de vitamine c, de carnitine et d’adenosine pour augmenter la densite capillaire
WO2021090070A3 (fr) Dose mesurée pour des troubles dans ou autour de l'œil
BR112017025600A2 (pt) ?composição e processo de tratamento cosmético?
MA50458A (fr) Formulations topiques destinées au traitement d'affections dermatologiques comprenant la calvitie hippocratique
CN111936473A8 (zh) 1,4-苯并二氮杂-2-酮衍生物及其应用
SG11201906907TA (en) Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180126

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8